2016

A new religion is emerging and it is spreading fast. Unlike religious takeovers of the past, there is no fight taking place. In fact, the followers of many o...

Does the Bible give us clue who planned the Trump shooting? Yes, and it's not who you think? What evidence do we have that Thomas Michael Crooks had help? Where was the second shooter located? Click here to watch this extraordinary Nelson Walters video to help make sense of recent events in the USA AND what to overcome the events in our near future.

How was Kamala Harris transformed from an embarrassing incompetent to the coolest, most inspirational leader in the world in a single day? Dr. Ben Carson on America’s North Korean media landscape. Watch more here: https://watchtcn.co/49CDF2t Subscribe to the new Tucker Carlson Network channel for more exclusive content: https://www.youtube.com/@TCNetwork/featured?sub_confirmation=1 Follow Tucker on X: https://x.com/TuckerCarlson Text “TUCKER” to 44055 for exclusive updates. Paid partnerships: Hillsdale College: Find free online course at https://TuckerforHillsdale.com PureTalk Wireless: Save 50% off your first month at https://PureTalk.com/Tucker Get the Parler app: https://parler.com #TuckerCarlson #DrBenCarson #DonaldTrump #KamalaHarris #JoeBiden #election #Christianity #health #doctor #Detroit #riots #DEI #advice #news #politics Chapters: 00:00 Intro 02:21 Kamala Harris 11:53 Donald Trump 26:36 Why the Black Community Loves Trump 32:34 Communism, Marxism, and the Left’s New Religion 44:59 Dr. Carson’s Success, Family, and Marriage Advice 01:05:36 Living Through the Detroit Riots 01:18:28 Why are American Men So Unhealthy? 01:29:24 Is There Any Hope of Getting Back to a System That People Trust? 01:33:01 Why the Swamp Is Afraid of Trump 01:36:53 The Evils of Abortion

To kickoff our new movie--"Out of Babel" (www.outofbabel.com), we wanted to interview our Native American consultants for the movie and friends, Chief Joseph RiverWind—a descendant of the Arawak Taino Tribe—and his wife, Dr. Laralyn of the Cherokee and Muskogee Creek. They tell a story about their special Journey to Israel were some meaningful things happened. Chief Joseph and Laralyn can be supported by visiting Firekeepers International (https://www.firekeepersinternational.org/)

What you’ve heard today should steer you clear of the Lodge. Many people watching today will choose to remain in the Lodge, fearful of losing business relationships. Others will dismiss this as a grand exaggeration. But some of you watching today will no doubt come to the realization who the god of Freemasonry really is … you’ve heard his secret name today … the false trinity of Jehovah, Baal and Osiris. Yes, it’s Lucifer the Great Deceiver, the hidden god of the Lodge. GET THE PACKAGE: https://prophecywatchers.com/product/the-secret-society-package-exposing-the-lies-of-the-lodge-by-billy-crone-ed-hindson-and-todd-hampson-shipping-included-in-the-usa/ We’re the Prophecy Watchers. We have a long history of working to bring the truth of Bible prophecy to an audience of Christian believers who may not have local access to sound prophetic teaching, based upon the inspired writings of the Apostles and the traditional doctrine concerning the rapture of the church. Though we don’t believe in setting dates, it is clear that the rapture of the church is imminent, perhaps much nearer than we think. DONATE: https://prophecywatchers.com/product/custom-donation-amount/ FIND US ON THE WEB: http://www.prophecywatchers.com TikTok: https://www.tiktok.com/@prophecywatchers IG: https://www.instagram.com/prophecy_watchers/ FOLLOW US ON FACEBOOK: http://facebook.com/prophecywatchers DOWNLOAD OUR APP: https://subsplash.com/prophecywatchers/app

Gabriel Caligiuri teaches Episode 78 of THE BOOK OF REVELATION series from Frontier Alliance International. GET THE NOTES // https://fai.online/mgbs/category/THE+BOOK+OF+REVELATION More MARANATHA GLOBAL BIBLE STUDY series are available at https://fai.online/mgbs FIVE DOLLAR MONTHLY GIVING CAMPAIGN // https://fai.online/five-dollar #becauseJesus MB01PTO3MXUVPID

WATCH THE FULL CONVERSATION: https://www.youtube.com/watch?v=JXgdmz9QZ5E&t=230s We’re the Prophecy Watchers. We have a long history of working to bring the truth of Bible prophecy to an audience of Christian believers who may not have local access to sound prophetic teaching, based upon the inspired writings of the Apostles and the traditional doctrine concerning the rapture of the church. Though we don’t believe in setting dates, it is clear that the rapture of the church is imminent, perhaps much nearer than we think. DONATE: https://prophecywatchers.com/product/custom-donation-amount/ FIND US ON THE WEB: http://www.prophecywatchers.com TikTok: https://www.tiktok.com/@prophecywatchers IG: https://www.instagram.com/prophecy_watchers/ FOLLOW US ON FACEBOOK: http://facebook.com/prophecywatchers DOWNLOAD OUR APP: https://subsplash.com/prophecywatchers/app

This 15 minute video is filled with prophetic morsels and topped off with Marsalus sauce. LA Marzulli connects with Bill Salus at the Prophecy Watchers Colorado Conference in June 2024. Although a short visit, they covered several topics including, the destruction of Damascus in Isaiah 17, Iran and its potential nuclear capabilities, Ezekiel 38 and also the Rapture. Thanks For Watching! Click the bell icon next to the SUBSCRIBE button to get alerts when a new video is uploaded. Visit Website: http://prophecydepot.com Read Daily News Reports: http://prophecynewsstand.blogspot.com Subscribe to Newsletter: http://prophecydepotministries.net Bill's Articles: http://prophecydepotministries.net/bills-articles/ Products: http://ecommerce.solutionsimplicity.com/index

Purpose: Dapagliflozin has been used extensively in patients with type 2 diabetes mellitus (T2DM). However, due to the potential diabetic ketoacidosis (DKA) risk of dapagliflozin, its use in type 1 diabetes mellitus (T1DM) is limited. Here, we reported an obese patient with T1DM and inadequat …

Dapagliflozin improves glycemic control in patients with type 2 diabetes mellitus (T2DM) and is approved in Japanese patients with type 1 diabetes mellitus (T1DM) with inadequate glycemic control. The objectives of this work were to characterize the dapagliflozin pharmacokinetics (PK) in patients wi …

At 24 months, the decline in eGFR was significantly lower in the dapagliflozin group than in the non-use group without increasing diabetic ketoacidosis and hypoglycemia.

Dapagliflozin 10 mg could achieve a better outcome in efficacy and could not increase the risk of hypoglycemia. Although it may induce a higher risk of DKA and genital infection, there was no significant difference between dapagliflozin 10 mg and 5 mg. Our outcomes indicate that dapagliflozin 10mg h …

These are the first reported cases of SIRS in which dapagliflozin, an SGLT-2 inhibitor, was used. The substantial reduction in the IM insulin dose following the addition of dapagliflozin in our reported cases of SIRS suggests a possible novel mechanism for dapagliflozin beyond its glucosuric effects …

The oral sodium-glucose cotransporter 2 inhibitor, dapagliflozin, is used to treat kidney disease, heart failure, and diabetes in adults, but has not been well studied in pediatrics, and does not have a recognized place in therapy in current practice guidelines. The purpose of this review is to summ …

The prevalence of type 1 diabetes (T1D) is increasing worldwide. T1D reduces life expectancy due to complications including cardiovascular disease. Sodium-glucose co-transporter (SGLT) inhibitors are a new class of drugs developed to treat type 2 diabetes (T2D), and now they can be used as an adjunc …

Dapagliflozin as adjunctive therapy to basal-bolus regime insulin in individuals with T1DM was well tolerated and improved glycemic control with no increase in hypoglycemia. We provide further evidence of the value of this intervention.

AstraZeneca.

Eight weeks of treatment with dapagliflozin did not restore hypoglycaemic awareness in people with T1DM and impaired awareness of hypoglycaemia, but ameliorated some clinical aspects.

Sodium glucose cotransporter-2 (SGLT2) is a sodium-dependent glucose transporter responsible for renal absorption of glucose. Dapagliflozin is an SGLT2 inhibitor used in patients with type 1 diabetes to promote urinary glucose excretion, but to date, randomized controlled trials (RCTs) to evaluate t …

Objective Young people with type 1 diabetes are likely to gain body weight and not achieve optimal glycemic control with only high doses of insulin. This study examined the efficacy of the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin as an adjunct-to-insulin therapy in young Japane …

To clarify the frequency of hypoglycemia in patients with type 1 diabetes mellitus receiving dapagliflozin combination therapy to reduce their basal insulin dose. Sixty subjects were assigned to two groups according to their basal insulin-to-total daily dose (TDD) ratio: group A (basal insulin/TDD & …

Efficacy and safety results from the Japanese subpopulation of the DEPICT-2 study were generally consistent with those from the overall population, indicating that long-term dapagliflozin adjunct to insulin therapy improves glycaemic control without an increased risk of hypoglycaemia but with a risk …

Over 52 weeks, dapagliflozin provided glycaemic and weight benefits, with no increased frequency of severe hypoglycaemia compared with placebo. More DKA events were reported with dapagliflozin than placebo, highlighting the importance of appropriate patient selection, education and risk-mitigation s …

Diabetic kidney disease is a worldwide epidemic, and therapies are incomplete. Clinical data suggest that improved renal outcomes by Na+-glucose cotransporter 2 inhibitor (SGLT2i) are partly beyond their antihyperglycemic effects; however, the mechanisms are still elusive. Here, we invest …

Dapagliflozin treatment benefits to reduce HbA1c and FPG for type 1 diabetes.

Dapagliflozin has been used to treat patients with type 1 diabetes mellitus; however, the actual drug efficacy of dapagliflozin on glycated hemoglobin (HbA1c) and whether there is a rebound from dapagliflozin efficacy on HbA1c remain unknown. The present study aimed to explore the actual therapeutic …